Roche Inks $1.7B Deal For Calif. Cancer-Drug Maker
Roche agreed to snap up California-based cancer-drug maker Ignyta Inc. in an all-cash deal worth roughly $1.7 billion that stands to grow the Swiss pharmaceutical and diagnostic company's oncology medicine portfolio,...To view the full article, register now.
Already a subscriber? Click here to view full article